Abstract
OBJECTIVES: To assess whether contralateral parenchymal enhancement reproduces as an independent biomarker for patient survival in an independent patient cohort from a different cancer institution.
METHODS: This is a HIPAA-compliant IRB approved retrospective study. Patients with ER-positive/HER2-negative operable invasive ductal carcinoma and preoperative dynamic contrast-enhanced MRI were consecutively included between 2005 and 2009. The parenchyma of the breast contralateral to known cancer was segmented automatically on MRI and contralateral parenchymal enhancement (CPE) was calculated. CPE was split into tertiles and tested for association with invasive disease-free survival (IDFS) and overall survival (OS). Propensity score analysis with inverse probability weighting (IPW) was used to adjust CPE for patient and tumour characteristics as well as systemic therapy.
RESULTS: Three hundred and two patients were included. The median age at diagnosis was 48 years (interquartile range, 42-57). Median follow-up was 88 months (interquartile range, 76-102); 15/302 (5%) patients died and 37/302 (13%) had a recurrence or died. In context of multivariable analysis, IPW-adjusted CPE was associated with IDFS [hazard ratio (HR) = 0.27, 95% confidence interval (CI) = 0.05-0.68, p = 0.004] and OS (HR = 0.22, 95% CI = 0.00-0.83, p = 0.032).
CONCLUSIONS: Contralateral parenchymal enhancement on pre-treatment dynamic contrast-enhanced MRI as an independent biomarker of survival in patients with ER-positive/HER2-negative breast cancer has been upheld in this study. These findings are a promising next step towards a practical and inexpensive test for risk stratification of ER-positive/HER2-negative breast cancer.
KEY POINTS: • High parenchymal-enhancement in the disease-free contralateral breast reproduces as biomarker for survival. • This is in patients with ER-positive/HER2-negative breast cancer from an independent cancer centre. • This is independent of patient and pathology parameters and systemic therapy.
Original language | English |
---|---|
Pages (from-to) | 4705-4716 |
Number of pages | 12 |
Journal | European Radiology |
Volume | 28 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2018 |
Keywords
- Unilateral breast neoplasms
- Magnetic resonance imaging
- Parenchymal tissue
- Survival analysis
- Image processing, computer-assisted
- Breast Neoplasms/diagnostic imaging
- Humans
- Middle Aged
- Neoplasm Recurrence, Local
- Proportional Hazards Models
- Magnetic Resonance Imaging/methods
- Parenchymal Tissue/diagnostic imaging
- Propensity Score
- Survival Analysis
- Biomarkers
- Adult
- Female
- Aged
- Contrast Media/administration & dosage
- Retrospective Studies